跳至主要内容
临床试验/IRCT2014050517581N1
IRCT2014050517581N1已完成3 期

Evaluation of the efficacy of ginger in reduction chemotherapy-induced nausea and vomiting in newly diagnosed breast cancer patients receiving doxorubicin(adriamycin)-based chemotherapy.

Shiraz University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • New diagnosed breast cancer ;All ages ;Female ;No previous chemotherapy ;Prescription of doxorubicin-based chemotherapy ;No gastrointestinal obstruction ;No coagulopathy ;Receiving of standard anti-emetic treatment ;Completion of ethic form ;No concurrent hormontherapy or radiotherapy.
  • Exclusion criteria:
  • Bleeding ;Development of gastrointestinal obstruction ;Uncompleted questionnaires ;Less than 3 cycle doxorubicin-based chemotherapy

排除标准

  • 未提供

研究者

相似试验